It’s Time to Prepare Your Lab to Grow

‘So Much Innovation Is Happening’

Episode 17 of the ASNC Interview Series features ASNC President Lawrence Phillips, MD, MASNC, and ASNC Past President Robert C. Hendel, MD, MASNC, being interviewed on takeaways from ASNC2024 by the meeting’s program chair, Renée Bullock-Palmer, MD, FASNC.

The interview is equal parts looking back at the success of ASNC2024 and considering what the meeting’s off-the-charts energy and enthusiasm signal for the field of nuclear cardiology.

ASNC2024 “checked all the boxes and beyond,” said Dr. Hendel, citing “on another level, really cutting edge” content, packed sessions, and vibrant participation of young people. “It’s so healthy and so wonderful.”

Drs. Hendel and Phillips applauded ASNC2024’s disease-based tracks, which allowed attendees to “look deeper” at new ways that nuclear cardiology is contributing to diagnosis and treatment even as they were gaining new skills and learning how best to partner with other imaging modalities and clinical areas. By combining disease-based tracks with sessions on innovations and new radiopharmaceuticals, ASNC2024 sent “everybody home with new pearls for better clinical practice,” Dr. Phillips said.

Importantly, ASNC2024 also revealed “where the future is and what changes labs need to make today,” Dr. Phillips emphasized. “We saw the evolution of nuclear cardiology taking place before our eyes.” This, he said, is why ASNC2024 Meeting OnDemand is a valuable tool for those who attended and those who missed it.

Nuclear Cardiology at a ‘Tipping Point’: Every Institution Should Be Making Changes Now

“We are at a tipping point in nuclear cardiology, where the field is going from where it has been over many years to an explosion in imaging in multiple disease states,” Dr. Phillips said. “This is a crucial time for every institution to be strategically planning for the next 5 to 10 years.”

ASNC2024 Meeting OnDemand includes 31 sessions highlighting how nuclear cardiology is expanding rapidly across amyloidosis, artificial intelligence, hybrid imaging, infection, inflammation, molecular imaging, myocardial blood flow quantification, radiopharmaceuticals, sarcoid, and much more.

“So much innovation is happening now,” Dr. Phillips explained, “but these are not techniques you just pick up and start doing the next day. There must be training. ASNC2024, combined with ASNC resources, is the key to success.”

Dr. Hendel also pointed to the value of ASNC2024 Meeting OnDemand. Following the FDA’s approval of F18-flurpiridaz, for example, many labs are looking for practical education on the soon-to-launch radiopharmaceutical. Others are looking for a “path forward” with artificial intelligence or a business strategy for adopting cardiac PET or hybrid imaging. “Go back and look at the ASNC meeting,” he said. “This is no longer something for ‘in the future.’ It’s now.”

This Is the Strategic-Planning Tool You Need Now

The pace at which nuclear cardiology is expanding is what makes ASNC2024 Meeting OnDemand a crucial tool for all nuclear cardiology professionals.

Order the OnDemand program –

• If you attended ASNC2024 in person or virtually. Watch sessions you missed or revisit presentations on topics that your team needs to understand now.
• If you missed ASNC2024. Catch up on advancements happening across the field and learn about changes you need to make now to prepare for nuclear cardiology’s exciting future.

Physicians may earn up to 28.25 CME credits with ASNC2024 Meeting OnDemand. 

Order Now